Navigation Links
Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year
Date:2/13/2008

new products-Renvela(R)

(sevelamer carbonate) in the United States, Synvisc-ONE(TM) (hylan

G-F 20) and Cholestagel(R) (colesevelam hydrochloride) in the

European Union, and Elaprase(R) (idursulfase) in Japan-and secured

expanded U.S. labeling for Campath(R) (alemtuzumab) and Thyrogen(R)

(thyrotropin alfa for injection).

-- Reported highly encouraging clinical trial results for two key late

stage product candidates: Mozobil(TM) (plerixafor) for stem-cell

transplantation and alemtuzumab for multiple sclerosis.

Fourth-Quarter 2007 Highlights

-- Revenue increased 21 percent in the fourth quarter to $1.04 billion, up

from $854.2 million in the prior fourth quarter.

-- GAAP net income increased to $78.9 million, or $0.29 per diluted share,

compared with an acquisition-related net loss of $268.2 million, or

$1.02 per diluted share, in the prior fourth quarter.

-- Non-GAAP net income increased 19 percent to $249.2 million, compared

with $209.0 million in the previous fourth quarter.

-- Non-GAAP earnings rose 18 percent to $0.91 per diluted share from

$0.77. The increased operating expenses and decreased interest income

associated with Genzyme's fourth-quarter acquisition of Bioenvision

reduced earnings by $0.01 per diluted share. The company had noted

previously that the impact of this transaction would be reflected in

its fourth-quarter results.

-- Individual product sales for the fourth quarter and the year, along

with expectations for the longer-term growth of Genzyme's business

segments, were detailed in a January 8, 2008, press release coinciding

with the company's presentation at the JPMorgan Healthcare Conference.

"We delivered outstanding financial results last year while continuing to build the company to meet our goa
'/>"/>

SOURCE Genzyme Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related medicine news :

1. Genzyme Receives FDA Response Letter on Synvisc-One(TM)
2. Bioenvision Shareholders Approve Acquisition by Genzyme Corporation
3. Genzyme Statement Regarding Results of FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
4. Genzyme and Bayer Schering Pharma AG, Germany to Present New Data on Alemtuzumab in Multiple Sclerosis at ECTRIMS
5. Delaware Court Approves Bioenvision, Genzyme Joint Petition
6. Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company
7. Liquent Insight Publisher 3.6 Delivers Advanced Submission Capabilities
8. March of Dimes Delivers a New Look
9. Independence Blue Cross Delivers Important Reminder to Women during Cervical Cancer Awareness Month
10. PARIs eFlow Delivers Alnylam RNAi Therapeutic in Phase I Study
11. Gleevec, the targeted cancer pill, delivers more good news to patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... The report “Nintedanib (Colorectal Cancer) ... on the current treatment landscape, unmet needs, current ... market. Stivarga is a drug which is used ... Boehringer Ingelheim is developing nintedanib (BIBF-1120), an orally ... CRC in the US, Europe, and Japan. The ...
(Date:12/25/2014)... three months the trends for evening dresses shift ... one of the hottest styles in the next few months.” ... releases 26 A-line sweetheart evening dresses, and announces the availability ... are trying our best to help a lady to show ... affordable prices, we provide discounted delivery costs to our customers ...
(Date:12/25/2014)... Angeles, CA (PRWEB) December 25, 2014 The ... Dolcemaschio was created in honor of a true 9/11 ... at two film festivals including the 24 hours of Nuremberg ... Festival in Bangladesh. , Actress, screenwriter and director ... helped produce this film together with her husband, Gregory ...
(Date:12/25/2014)... Helen Harris’ RP (Retinitis Pigmentosa) International ... after an 8 year battle with breast cancer. ... in her home in Woodland Hills California after an ... , As the founder and volunteer President ... and championed many of today's greatest breakthroughs in restoring ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, 2014 ... can receive effective, less expensive care from a clinic that ... team of dedicated health care professionals, a new study shows. ... need either hospitalization or a trip to the emergency room ... at the University of Texas in Houston versus usual care, ...
Breaking Medicine News(10 mins):Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3
... Dr. Robert S. Bray, Jr. of ... D.I.S.C. Spine and Sports Center, ... dream after successfully qualifying for the 2008 Olympics Saturday in,Atlanta ... country,s preeminent,neurological spinal surgeons specializing in micro procedures. Bray,performed a ...
... Appears Superior to Standard Therapy for Eradicating H. ... trials comparing sequential and standard triple therapies in ... infection found that sequential therapy appears superior to ... infection. , Authors say if further trials ...
... The St. Jude Dream Home(R) in,Hurricane, W. Va., is ... CertainTeed Gypsum Plant in nearby Moundsville, W. Va. To ... CertainTeed is,donating gypsum wallboard and roofing shingles that will ... ), The 3,100 square foot St. Jude Dream ...
... FLARE Santa,Clara HIV County Collaborative: PACE Clinic, Asian ... Lesbian and Gay Community,Center, Song That Radio, Santa ... Wellness Center present a performance art contest at,DeAnza ... 11 to 2 PM., The midday celebration ...
... SANTA PAULA, Calif., May 19 Today, the ... provides the,most highly trained canine-firefighter disaster search teams ... $4.1 million 122-acre ranch site in Santa,Paula, California, ... its kind.,The National Training Center (NTC) will allow ...
... skin open to infection, study says , , MONDAY, ... polyalkylimide implant injections may cause infrequent, but sometimes severe, ... , These implants, which consist of gel and ... such as the lips, cheeks, forehead and lines that ...
Cached Medicine News:Health News:Successful Back Surgery Propels Olympic Weightlifting Hopeful Melanie Roach to Realize Her Dreams Of Participating in the 2008 Beijing Olympics 2Health News:Gypsum Wallboard from CertainTeed's Moundsville, W. Va., Plant and Roofing Shingles among Building Materials Donated to St. Jude Dream Home(R) 2Health News:National Disaster Search Dog Foundation Plans New Training Facility in Santa Paula, California 2Health News:Cosmetic Skin Fillers May Cause Delayed Side Effects 2
(Date:12/24/2014)... Dec. 23, 2014 In response to urgent requests ... Sierra Leone , Direct Relief delivered two ... for the treatment of local health workers who contract Ebola ... dedicated Ebola care center was constructed for foreign health care ... not available for local Sierra Leonean health workers. ...
(Date:12/22/2014)... NxStage Medical, Inc. (NASDAQ: NXTM ... announced today that the U.S. Food and Drug ... perform hemodialysis overnight while the patient is at ... System One is the first and only hemodialysis ... Home nocturnal hemodialysis is an ...
(Date:12/22/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/hmlfbq/investment ) ... Analysis of the US Medical Device Sector " ... http://photos.prnewswire.com/prnh/20130307/600769 This analysis ... identifies the key trends and rationale for undertaking ... and acquisitions. The study will be ...
Breaking Medicine Technology:First Ebola Treatment Unit for Local Health Workers Arrives in Sierra Leone 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3Investment Analysis of the US Medical Device Sector 2
... 2011 Pacira Pharmaceuticals, Inc., (Nasdaq: ... announced that positive results from its Phase 3 ... be presented at the 2011 American Society of ... in Vancouver, British Columbia. Results from this multicenter, ...
... VOLC ) today announced its participation in the ... Volcano,s focus will be on highlighting the strength of its ... Balloon Catheter (VIBE® RX), and its sponsorship of a symposium ... in clinical practice today. "Volcano is excited ...
Cached Medicine Technology:Pacira Pharmaceuticals, Inc. Announces Phase 3 EXPAREL™ Data Presentation at the American Society of Colon and Rectal Surgeons 2011 Annual Meeting 2Pacira Pharmaceuticals, Inc. Announces Phase 3 EXPAREL™ Data Presentation at the American Society of Colon and Rectal Surgeons 2011 Annual Meeting 3Pacira Pharmaceuticals, Inc. Announces Phase 3 EXPAREL™ Data Presentation at the American Society of Colon and Rectal Surgeons 2011 Annual Meeting 4Pacira Pharmaceuticals, Inc. Announces Phase 3 EXPAREL™ Data Presentation at the American Society of Colon and Rectal Surgeons 2011 Annual Meeting 5Volcano to Highlight its Precision Guided Therapy Technologies at EuroPCR 2Volcano to Highlight its Precision Guided Therapy Technologies at EuroPCR 3Volcano to Highlight its Precision Guided Therapy Technologies at EuroPCR 4
The standard-sized titanium port may be ordered with a silicone or polyurethane catheter. The silicone catheter is available with inner diameter sizes of 0.9, 1.0, 1.4, 1.6 mm. The polyurethane cathe...
Small size means convenient set up in any cath lab. ,System so versatile it can be mounted on I.V. pole or bedside, or bagged in sterile field....
... Alsius heat exchange catheters connect to the ... and maintains a target temperature input by ... patient core temperature and automatically adjusts the ... catheter (0-42C), providing consistent maintenance of temperature. ...
Used for vascular access. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: